Published in Blood Weekly, August 18th, 2005
StemCyte, Inc., and its subsidiary in Taiwan, maintain one of the largest and most ethnically diverse collections of donated cord blood stem cells in the world and have now provided transplant and cancer centers with umbilical cord blood units for over 200 stem cell transplantation procedures worldwide. Cord blood stem cells have proven to be an effective substitute for traditional...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.